Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.51 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | HTT | P42858 | 3/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | TTR | P02766 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29697071 | 1.00 | TSHR (0.57) | TSHRKMT2AMEN1POLBL3MBTL1 | |
| SCHEMBL623566 | 0.89 | ALDH1A1 (0.54) | TSHRKMT2AMEN1POLBCA1 | |
| SCHEMBL29975615 | 0.84 | KMT2A (0.53) | TSHRKMT2AMEN1POLBL3MBTL1 | |
| Dinitolmide SCHEMBL29360311 | 0.84 | ALDH1A1 (0.68) | TSHRKMT2AMEN1POLBL3MBTL1 | |
| Dinitolmide SCHEMBL43712 | 0.84 | ALDH1A1 (0.68) | TSHRKMT2AMEN1POLBL3MBTL1 | |
| SCHEMBL27860074 | 0.84 | KMT2A (0.53) | TSHRKMT2AMEN1POLBL3MBTL1 | |
| SCHEMBL6830067 | 0.84 | TSHR (0.59) | TSHRKMT2AMEN1POLBL3MBTL1 | |
| SCHEMBL30406917 | 0.84 | ALDH1A1 (0.50) | TSHRKMT2AMEN1POLBALDH1A1 | |
| SCHEMBL89086 | 0.84 | ALDH1A1 (0.50) | TSHRKMT2AMEN1POLBALDH1A1 | |
| SCHEMBL11326653 | 0.83 | KMT2A (0.60) | TSHRKMT2AMEN1POLBL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 446 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-116836081-A | Ether epoxy toughening agent and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-10-03 | — | — | CN | claimed |
| CN-113149845-B | Preparation method of 3, 5-dinitro-2-methylbenzoic acid | 台州学院 | 2022-07-05 | — | — | CN | claimed |
| US-20220010029-A1 | HYBRIDOMA CELL STRAIN THAT SECRETS ANTI-DINITOLMIDE MONOCLONAL ANTIBODIES AND THE APPLICATION OF HYBRIDOMA CELL STRAIN | JIANGNAN UNIVERSITY | 2022-01-13 | — | — | US | claimed |
| CN-113149845-A | Preparation method of 3, 5-dinitro-2-methylbenzoic acid | 台州学院 | 2021-07-23 | — | — | CN | claimed |
| CN-111763658-A | Hybridoma cell strain secreting anti-dinitrotolamine monoclonal antibody and application thereof | 江南大学 | 2020-10-13 | — | — | CN | claimed |
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-09-11 | — | — | US | claimed |
| US-9527801-B2 | Process and device for recycling waste acid produced in process of producing zoalene | Zhejiang Rongyao Biotech CO., LTD. (CN) | 2016-12-27 | — | — | US | claimed |
| CN-105906523-A | Synthesis method of zoalene | 浙江荣耀生物科技有限公司 | 2016-08-31 | — | — | CN | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| US-6306203-B1 | FOR USE IN INK JET PRINTING, INCLUDING PIEZOELECTRIC INK JET PRINTING AND ACOUSTIC INK JET PRINTING | XEROX CORPORATION | 2001-10-23 | — | — | US | claimed |
| US-5527708-A | MEASURING FLUORESCENCE FROM REACTION OF CREATININE AND 3,5-DINITROBENZOATES OR 3,5-DINITROBENZAMIDE | BLASS KARL G (CA) | 1996-06-18 | — | — | US | claimed |
| EP-0055616-A1 | Antibacterial compounds | BEECHAM GROUP PLC (GB) | 1982-07-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | PTPRCAP, PTPRF, PTPRS | TSHR 1605/4885KMT2A 2681/4885MEN1 4428/4885 |
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | TSHR 2894/4885KMT2A 1624/4885MEN1 685/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | TSHR 4082/4885KMT2A 826/4885MEN1 1466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.